[Infections during antineoplastic drug therapy. Use of the sulfamethoxazole-trimethoprim association].
D000890:Anti-Infective Agents / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004338:Drug Combinations; D004361:Drug Tolerance; D005260:Female; D005493:Folic Acid Antagonists / Q000008:administration & dosage*; D006801:Humans; D007239:Infections / Q000188:drug therapy*; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*; D011743:Pyrimidines / Q000008:administration & dosage*; D013420:Sulfamethoxazole / Q000008:administration & dosage*; D014295:Trimethoprim / Q000008:administration & dosage
D000890:Anti-Infective Agents; D000970:Antineoplastic Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Infections au cours des chimiothérapies anti-cancéreuses. Utilisation de l'association sulfaméthoxazole-triméthoprime.